However, it is unfortunate that it was not possible to draw a conclusion about how much the anti-cancer effect of AIMs is reduced in the situation where TNF-α is highly observed in the in vitro study, and whether AIMs will exert the anti-cancer effect in the situation where the actual TNF-α is high, such as highly metastatic cancer or far advanced cancers. The gene discussed is TNF; the disease is cancer.